Zenith Drugs Limited - Company Profile

Q: Where is Zenith Drugs Limited headquartered?

Zenith Drugs Limited is headquartered at K. No. 725, Village Muradpura, Depalpur, Madhya Pradesh, 453001.

Q: Who are the current directors of Zenith Drugs Limited?

The current directors of Zenith Drugs Limited are Deendayal Kumawat, Ajay Singh Dassundi, Anil Malik, Bhupesh Soni, Sandeep Bhardwaj, Ranjana Sehgal, Neeraj Pandey, Rajesh Agrawal.

It is a pharma public limited company based in Depalpur, Madhya Pradesh, India, established in 2000.

2000 Depalpur, Madhya Pradesh, India Active

Last Updated: January 04, 2026

Access Report

About Zenith Drugs Limited

Zenith Drugs Limited, a active public limited company, was established on 15 November 2000 in Depalpur, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24231MP2000PLC014465. Registered under ROC Roc Gwalior. it is listed. It has an authorized capital of ₹22.40 Cr and a paid-up capital of ₹17.15 Cr.

It upholds a compliant status. In 2024, it reported revenue of ₹133.74 Cr and a net worth of ₹62.22 Cr. Employing 99 professional, Its leadership includes Deendayal Kumawat (Director), Ajay Singh Dassundi (Director), Anil Malik (Director). Past directors included Ajay Singh Dassundi, Sandeep Bhardwaj. It holds ₹110.89 Cr open charges and ₹109.84 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at K. No. 72/5, Village Muradpura, Depalpur, Madhya Pradesh, 453001.

Company Details

CIN/LLPIN
L24231MP2000PLC014465
Registration Number
014465
Incorporation Date
15 November 2000
Authorized Capital
₹22.40 Cr
Paid-Up Capital
₹17.15 Cr
ROC Code
Roc Gwalior
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 22.40 Cr as on 04-01-2026
Paid Up Capital ₹ 17.15 Cr as on 04-01-2026
Company Age 25 Year, 2 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 110.89 Cr as on 04-01-2026
Satisfied Charges ₹ 109.84 Cr as on 04-01-2026

Comprehensive Company Insights

Explore comprehensive insights into Zenith Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Zenith Drugs Limited?

Current Directors

Name	Designation	Appointment Date	Status
Deendayal Kumawat	Director	25 Sep 2023	Current
Ajay Singh Dassundi	Director	25 Jun 2015	Current
Anil Malik	Director	25 Sep 2023	Current
Bhupesh Soni	Director	15 Mar 2001	Current
Sandeep Bhardwaj	Managing Director	31 Oct 2003	Current
Ranjana Sehgal	Director	16 Sep 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Mar 2012	Past
Pramod Abcsdd	Director	15 Sep 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zenith Drugs.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zenith Drugs?

Unlock access to Zenith Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,108,859,653.00

Satisfied Charges

₹1,098,385,000.00

Charges Breakdown by Lending Institutions

Sbicap Trustee Company Limited : 76.98 Cr
Hdfc Bank Limited : 26.94 Cr
Sidbi : 6.20 Cr
Others : 0.67 Cr
Union Bank Of India : 0.09 Cr

Latest Charge Details

Date	Lender	Amount	Status
22 Sep 2025	Sidbi	₹9.20 M	Open
26 Mar 2025	Sidbi	₹2.03 Cr	Open
10 Mar 2025	Sbicap Trustee Company Limited	₹76.98 Cr	Open
17 Oct 2024	Others	₹5.19 M	Open
26 Jun 2024	Sidbi	₹7.50 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Zenith Drugs?

Unlock and access historical data on people associated with Zenith Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zenith Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenith Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zenith Drugs

Recent Activity within the Organization

Director Appointment

Progress on Rajesh Agrawal was appointed as a Cfo was appointed as a Cfo on 13 Dec 2025 & has been associated with this company since 1 month 26 days . was documented.
13 Dec 2025
Annual General Meeting

Progress on Zenith Drugs Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.
29 Sep 2025
Charges

The activity A charge with Sidbi amounted to Rs. 0.92 Cr with Charge ID 101184755 was registered on 22 Sep 2025. was completed.
22 Sep 2025
Balance Sheet

Zenith Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.
31 Mar 2025
Charges

A charge with Sidbi amounted to Rs. 2.03 Cr with Charge ID 101074698 was registered on 26 Mar 2025. was recorded as a recent event.
26 Mar 2025
Charges

Progress on A charge registered on 19 Oct 2024 via Charge ID 101000220 with State Bank Of India was fully satisfied on 20 Mar 2025. was documented.
20 Mar 2025

Explore recent activity and updates - View Recent Activity